Business
Nektar Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference in New York
Nektar Therapeutics (Nasdaq: NKTR) today announced that company management will be webcasting its participation in the 2026 Jefferies Global Healthcare Conference being held June 2-4, 2026 in New York.
About this update from Nektar Therapeutics
[{"type":"text","content":"SAN FRANCISCO, May 27, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that company management will be webcasting its participation in the 2026 Jefferies Global Healthcare Conference being held June 2-4, 2026 in New York.","length":255,"tagName":"p"},{"type":"image","alt":"Nektar Logo (PRNewsfoto/Nektar Therapeutics)","displaySize":"","headline":null,"caption":"Nektar Logo (PRNewsfoto/Nektar Therapeutics)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":145,"url":"https://media.zenfs.com/en/prnewswire.com/e9141883926ab6553b7ec849fd9c6537"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0s2k54me9FiZs8HTjKisRQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI1Ng--/https://media.zenfs.com/en/prnewswire.com/e9141883926ab6553b7ec849fd9c6537","width":400,"height":145},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/z7zqcjPGpYTMSD.7ePWmnw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTIzMg--/https://media.zenfs.com/en/prnewswire.com/e9141883926ab6553b7ec849fd9c6537","width":400,"height":145}},"href":"https://mma.prnewswire.com/media/1390052/Nektar_Logo_v1.html","hrefExternal":true,"rel":"nofollow"},{"type":"list","items":[{"val":[{"type":"text","content":"2026 Jefferies Global Healthcare Conference in New York on Wednesday, June 3, 2026 – webcast to be available at 1:20 p.m. Eastern Time – webcast link here","length":154,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":154,"olType":false},{"type":"text","content":"The fireside chat will be accessible via the webcast link above as well as on the Investor Events section of the Nektar website: https://ir.nektar.com/events-and-presentations/events. A replay of the fireside chat will be available for 30 days.","length":249,"tagName":"p"},{"type":"text","content":"If you would like to request a one-on-one meeting with company management during the conference, please reach out to your respective representative.","length":148,"tagName":"p"},{"type":"text","content":"About Nektar Therapeutics","length":25,"tagName":"p"},{"type":"text","content":"Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases. Nektar's lead product candidate, rezpegaldesleukin (REZPEG, or NKTR-358)...